Yoichi Ueta Selected Research

Galanin-Like Peptide

5/2007	Induction of the galanin-like peptide gene expression in the posterior pituitary gland after acute osmotic stimulus in rats.
2/2005	Galanin-like peptide stimulates vasopressin, oxytocin and adrenocorticotropic hormone release in rats.
6/2004	Galanin-like peptide gene expression in the hypothalamus and posterior pituitary of the obese fa/fa rat.
5/2003	Induction of galanin-like peptide gene expression in the rat posterior pituitary gland during endotoxin shock and adjuvant arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoichi Ueta Research Topics

Disease

13	Anorexia 01/2020 - 01/2007
10	Neoplasms (Cancer) 07/2020 - 01/2004
8	AIDS-Related Complex (ARC) 11/2014 - 09/2002
6	Obesity 01/2022 - 10/2004
6	Cachexia 01/2018 - 12/2007
5	Body Weight (Weight, Body) 12/2021 - 10/2004
5	Experimental Arthritis 01/2020 - 05/2003
5	Inflammation (Inflammations) 01/2020 - 09/2015
5	Dehydration (Water Stress) 01/2018 - 01/2002
4	Hypovolemia 01/2022 - 01/2010
4	Pain (Aches) 01/2016 - 05/2004
3	Neuralgia (Stump Neuralgia) 09/2021 - 05/2019
3	Arthritis (Polyarthritis) 01/2020 - 05/2011
3	Hyperphagia (Overeating) 06/2019 - 12/2008
3	Septic Shock (Toxic Shock Syndrome) 02/2011 - 05/2003
2	Weight Loss (Weight Reduction) 01/2022 - 02/2014
2	Shock 10/2013 - 02/2005
2	Seizures (Absence Seizure) 07/2012 - 11/2011
2	Brain Injuries (Brain Injury) 01/2012 - 02/2003
2	Cystitis 12/2009 - 08/2004
2	Fever (Fevers) 11/2009 - 04/2006
2	Insulin Resistance 07/2007 - 10/2004
2	Glucose Intolerance 01/2005 - 10/2004
1	Hyperalgesia 01/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Knee Osteoarthritis 01/2020
1	Hyperglycemia 06/2019
1	Vomiting 07/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Diabetes Insipidus 02/2012
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 02/2012
1	Hypotension (Low Blood Pressure) 09/2011
1	Lung Neoplasms (Lung Cancer) 05/2011
1	Melanoma (Melanoma, Malignant) 05/2011
1	Hypercalcemia (Milk Alkali Syndrome) 05/2011
1	Chronic Pain 02/2011

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2020 - 01/2007
9	Oxytocin (Pitocin)FDA LinkGeneric 01/2022 - 10/2010
9	Messenger RNA (mRNA)IBA 07/2014 - 06/2004
7	Arginine Vasopressin (Argipressin)IBA 01/2020 - 02/2011
7	NeuropeptidesIBA 10/2019 - 10/2004
5	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 11/2014 - 09/2002
5	LeptinIBA 05/2011 - 10/2004
4	enhanced green fluorescent proteinIBA 01/2022 - 09/2009
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 01/2010
4	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 08/2013
4	Corticotropin-Releasing HormoneIBA 01/2020 - 08/2004
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2010
4	Red Fluorescent ProteinIBA 01/2020 - 01/2016
4	AdrenomedullinIBA 01/2011 - 11/2002
4	OrexinsIBA 12/2009 - 09/2002
4	LipopolysaccharidesIBA 11/2009 - 02/2005
4	Galanin-Like PeptideIBA 05/2007 - 05/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2004
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020 - 08/2004
3	Hormones (Hormone)IBA 01/2020 - 02/2007
3	GhrelinIBA 03/2018 - 01/2010
3	liu-jun-zi-tangIBA 01/2017 - 08/2013
3	Neuropeptide YIBA 08/2013 - 09/2002
3	SaltsIBA 02/2011 - 01/2002
3	Protein Isoforms (Isoforms)IBA 06/2009 - 01/2005
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2009
2	Angiotensin IIIBA 01/2018 - 01/2010
2	Formaldehyde (Formol)FDA Link 01/2016 - 09/2015
2	Amphetamine (Amfetamine)FDA LinkGeneric 08/2013 - 01/2007
2	Cocaine (Cocaine HCl)IBA 08/2013 - 01/2007
2	Kainic Acid (Kainate)IBA 07/2012 - 11/2011
2	LC 6IBA 05/2011 - 01/2007
2	Parathyroid Hormone-Related ProteinIBA 05/2011 - 01/2007
2	Vasopressins (Vasopressin)IBA 10/2010 - 07/2005
2	Amino Acids FDA Link 10/2010 - 05/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2009 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 02/2007
2	ProstaglandinsIBA 04/2006 - 02/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 07/2005 - 12/2003
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	CarrageenanIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 06/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2018
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 07/2018
1	Appetite Depressants (Anorectics)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2016
1	oxytocin-saporinIBA 01/2016
1	Ion Channels (Ion Channel)IBA 09/2015
1	Drinking WaterIBA 07/2014
1	Serum AlbuminIBA 02/2014
1	CorticosteroneIBA 10/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2012
1	Liver X ReceptorsIBA 02/2012
1	oxysterol binding proteinIBA 02/2012
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2012
1	hydroxide ionIBA 05/2011

Therapy/Procedure

3	Ligation 09/2021 - 05/2019
2	Therapeutics 01/2017 - 09/2015
2	Oral Administration 02/2014 - 05/2011
1	Analgesia 01/2021
1	Kampo Medicine (Kampo) 01/2017
1	Fluid Therapy (Oral Rehydration Therapy) 07/2014
1	Adrenalectomy 02/2011